Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Lifeward Ltd.RWLK · Entity 7620 | 10% owner | June 26, 2017 | June 28, 2017 |
| Societal CDMO, Inc.REPH · Entity 92137 | Director | November 23, 2015 | November 03, 2016 |
| VISHAY INTERTECHNOLOGY INCVSH · Entity 3973 | Director | January 02, 2026 | January 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Lifeward Ltd.
Report date June 26, 2017 · Filed June 28, 2017
Jointly reported with SCP Vitalife Partners (Israel) II, L.P., SCP Vitalife II Associates, L.P., SCP Vitalife II GP, Ltd., CHURCHILL WINSTON J
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, par value NIS 0.01 per shareSEC Table I · non-derivative | Direct | 339,900 |
Last balance in matching sequence
After 2017-06-27 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2017-06-26 · Sale · Disposed 9,271 · Balance 352,411 F1: Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 15, 2016. F2: The Ordinary Shares are directly held by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife") and indirectly held by SCP Vitalife II Associates, L.P. ("SCP Vitalife Associates"), the sole general partner of SCP Vitalife, SCP Vitalife II, GP, Ltd. ("SCP Vitalife GP"), the sole general partner of SCP Vitalife Associates, and the individual directors of SCP Vitalife GP (SCP Vitalife Associates, SCP Vitalife GP and the individual directors of SCP Vitalife GP together, the "SCP Vitalife Indirect Reporting Persons"). The individual directors of SCP Vitalife GP are Jeffrey Dykan, Winston J. Churchill, Abraham Ludomirski and Wayne B. Weisman. The SCP Vitalife Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the SCP Vitalife Ordinary Shares in which the SCP Vitalife Indirect Reporting Persons have no pecuniary interest. Row 2 · 2017-06-27 · Sale · Disposed 12,511 · Balance 339,900 F1: Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 15, 2016. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.0000 to $3.2000, inclusive. The reporting person undertakes to provide to ReWalk Robotics, Ltd. ("ReWalk"), any security holder of ReWalk, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F2: The Ordinary Shares are directly held by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife") and indirectly held by SCP Vitalife II Associates, L.P. ("SCP Vitalife Associates"), the sole general partner of SCP Vitalife, SCP Vitalife II, GP, Ltd. ("SCP Vitalife GP"), the sole general partner of SCP Vitalife Associates, and the individual directors of SCP Vitalife GP (SCP Vitalife Associates, SCP Vitalife GP and the individual directors of SCP Vitalife GP together, the "SCP Vitalife Indirect Reporting Persons"). The individual directors of SCP Vitalife GP are Jeffrey Dykan, Winston J. Churchill, Abraham Ludomirski and Wayne B. Weisman. The SCP Vitalife Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the SCP Vitalife Ordinary Shares in which the SCP Vitalife Indirect Reporting Persons have no pecuniary interest. |
Filing footnotes · ownership attribution and instrument terms
F1: Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 15, 2016.
F2: The Ordinary Shares are directly held by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife") and indirectly held by SCP Vitalife II Associates, L.P. ("SCP Vitalife Associates"), the sole general partner of SCP Vitalife, SCP Vitalife II, GP, Ltd. ("SCP Vitalife GP"), the sole general partner of SCP Vitalife Associates, and the individual directors of SCP Vitalife GP (SCP Vitalife Associates, SCP Vitalife GP and the individual directors of SCP Vitalife GP together, the "SCP Vitalife Indirect Reporting Persons"). The individual directors of SCP Vitalife GP are Jeffrey Dykan, Winston J. Churchill, Abraham Ludomirski and Wayne B. Weisman. The SCP Vitalife Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the SCP Vitalife Ordinary Shares in which the SCP Vitalife Indirect Reporting Persons have no pecuniary interest.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.0000 to $3.2000, inclusive. The reporting person undertakes to provide to ReWalk Robotics, Ltd. ("ReWalk"), any security holder of ReWalk, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
Societal CDMO, Inc.
Report date November 23, 2015 · Filed November 03, 2016 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
Holding disclosure · report date 2015-11-23 · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · Balance 0 F1: On May 23, 2016, the reporting person filed a Form 4 mistakenly reporting indirect beneficial ownership for shares of common stock owned by SCP Vitalife Partners (Israel) II, L.P. and SCP Vitalife Partners II L.P and sold in fourteen transactions occurring between November 23, 2015 through May 20, 2016, which consisted of the sale of an aggregate of 58,331 shares of common stock. During the period from November 23, 2015 through May 20, 2016, the reporting person did not have indirect beneficial ownership of such shares. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 23, 2016, the reporting person filed a Form 4 mistakenly reporting indirect beneficial ownership for shares of common stock owned by SCP Vitalife Partners (Israel) II, L.P. and SCP Vitalife Partners II L.P and sold in fourteen transactions occurring between November 23, 2015 through May 20, 2016, which consisted of the sale of an aggregate of 58,331 shares of common stock. During the period from November 23, 2015 through May 20, 2016, the reporting person did not have indirect beneficial ownership of such shares.
VISHAY INTERTECHNOLOGY INC
Report date January 02, 2026 · Filed January 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 93,250 |
Reported balance
After 2026-01-02 transaction · row 1
1 source rowRow 1 · 2026-01-02 · Grant · Acquired 13,802 · Balance 93,250 F1: Represents the number of restricted stock units granted to the Reporting Person on January 2, 2026 as part of the Registrant's 2023 Long-Term Incentive Plan. The restricted stock units vest upon the completion of the three-year period ending January 1, 2029. In the event that the services of the Reporting Person cease prior to the expiration of such three-year period, the restricted stock units will vest upon the cessation of service, provided however that the number of restricted stock units that vest will be reduced pro rata to the extent of the portion of the three-year period not served. Each restricted stock unit represents a right to receive one share of the Registrant's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of restricted stock units granted to the Reporting Person on January 2, 2026 as part of the Registrant's 2023 Long-Term Incentive Plan. The restricted stock units vest upon the completion of the three-year period ending January 1, 2029. In the event that the services of the Reporting Person cease prior to the expiration of such three-year period, the restricted stock units will vest upon the cessation of service, provided however that the number of restricted stock units that vest will be reduced pro rata to the extent of the portion of the three-year period not served. Each restricted stock unit represents a right to receive one share of the Registrant's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2026 Filed Jan 5, 2026 23:32 UTC | VISHAY INTERTECHNOLOGY INC VSH · Entity 3973 | GrantCommon Stock | 13,802 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-26-000035 · form4.xml · nonDerivative · entry 1 LUDOMIRSKI ABRAHAM · CIK 0001235402 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,250 F1 · shares: Represents the number of restricted stock units granted to the Reporting Person on January 2, 2026 as part of the Registrant's 2023 Long-Term Incentive Plan. The restricted stock units vest upon the completion of the three-year period ending January 1, 2029. In the event that the services of the Reporting Person cease prior to the expiration of such three-year period, the restricted stock units will vest upon the cessation of service, provided however that the number of restricted stock units that vest will be reduced pro rata to the extent of the portion of the three-year period not served. Each restricted stock unit represents a right to receive one share of the Registrant's common stock. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 22:13 UTC | VISHAY INTERTECHNOLOGY INC VSH · Entity 3973 | GrantCommon Stock | 10,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-000420 · form4.xml · nonDerivative · entry 1 LUDOMIRSKI ABRAHAM · CIK 0001235402 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,448 F1 · shares: Represents the number of restricted stock units granted to the Reporting Person on January 2, 2025 as part of the Registrant's 2023 Long-Term Incentive Plan. The restricted stock units vest upon the completion of the three-year period ending January 1, 2028. In the event that the services of the Reporting Person cease prior to the expiration of such three-year period, the restricted stock units will vest upon the cessation of service, provided however that the number of restricted stock units that vest will be reduced pro rata to the extent of the portion of the three-year period not served. Each restricted stock unit represents a right to receive one share of the Registrant's common stock. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 21:30 UTC | VISHAY INTERTECHNOLOGY INC VSH · Entity 3973 | GrantCommon Stock | 7,509 | $0.00 | $0.00 |
DisclosureSEC source: 0000103730-24-000003 · form4.xml · nonDerivative · entry 1 LUDOMIRSKI ABRAHAM · CIK 0001235402 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,822 F1 · shares: Represents the number of restricted stock units granted to the Reporting Person on January 2, 2024 as part of the Registrant's 2023 Long-Term Incentive Plan. The restricted stock units vest upon the completion of the three-year period ending January 1, 2027. In the event that the services of the Reporting Person cease prior to the expiration of such three-year period, the restricted stock units will vest upon the cessation of service, provided however that the number of restricted stock units that vest will be reduced pro rata to the extent of the portion of the three-year period not served. Each restricted stock unit represents a right to receive one share of the Registrant's common stock. Read SEC document |
| December 18, 2023 Filed Dec 19, 2023 21:32 UTC | VISHAY INTERTECHNOLOGY INC VSH · Entity 3973 | SaleCommon Stock | 75,049 | $23.84 | $1,789,168.16 |
DisclosureSEC source: 0000103730-23-000099 · form4.xml · nonDerivative · entry 1 LUDOMIRSKI ABRAHAM · CIK 0001235402 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,313 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.64 to $23.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of each separate price within the ranges set forth in this footnote to the Form 4. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 22:33 UTC | VISHAY INTERTECHNOLOGY INC VSH · Entity 3973 | GrantCommon Stock | 8,345 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-000313 · doc1.xml · nonDerivative · entry 1 LUDOMIRSKI ABRAHAM · CIK 0001235402 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,362 F1 · shares: Represents the number of restricted stock units granted to the Reporting Person on January 3, 2023 as part of the Registrant's 2007 Stock Incentive Program. The restricted stock units vest upon the completion of the three-year period ending January 1, 2026. In the event that the services of the Reporting Person cease prior to the expiration of such three-year period, the restricted stock units will vest upon the cessation of service, provided however that the number of restricted stock units that vest will be reduced pro rata to the extent of the portion of the three-year period not served. Each restricted stock unit represents a right to receive one share of the Registrant's common stock. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 01:06 UTC | VISHAY INTERTECHNOLOGY INC VSH · Entity 3973 | GrantCommon Stock | 8,230 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-000095 · doc1.xml · nonDerivative · entry 1 LUDOMIRSKI ABRAHAM · CIK 0001235402 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,017 F1 · shares: Represents the number of restricted stock units granted to the Reporting Person on January 3, 2022 as part of the Registrant's 2007 Stock Incentive Program. The restricted stock units vest upon the completion of the three-year period ending January 1, 2025. In the event that the services of the Reporting Person cease prior to the expiration of such three-year period, the restricted stock units will vest upon the cessation of service, provided however that the number of restricted stock units that vest will be reduced pro rata to the extent of the portion of the three-year period not served. Each restricted stock unit represents a right to receive one share of the Registrant's common stock. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 01:24 UTC | VISHAY INTERTECHNOLOGY INC VSH · Entity 3973 | GrantCommon Stock | 8,691 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-000109 · doc1.xml · nonDerivative · entry 1 LUDOMIRSKI ABRAHAM · CIK 0001235402 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,787 F1 · shares: Represents the number of restricted stock units granted to the Reporting Person on January 4, 2021 as part of the Registrant's 2007 Stock Incentive Program. The restricted stock units vest upon the completion of the three-year period ending January 1, 2024. In the event that the services of the Reporting Person cease prior to the expiration of such three-year period, the restricted stock units will vest upon the cessation of service, provided however that the number of restricted stock units that vest will be reduced pro rata to the extent of the portion of the three-year period not served. Each restricted stock unit represents a right to receive one share of the Registrant's common stock. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 00:25 UTC | VISHAY INTERTECHNOLOGY INC VSH · Entity 3973 | GrantCommon Stock | 7,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-000145 · doc1.xml · nonDerivative · entry 1 LUDOMIRSKI ABRAHAM · CIK 0001235402 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,096 F1 · shares: Represents the number of restricted stock units granted to the Reporting Person on January 2, 2020 part of the Registrant's 2007 Stock Incentive Program. The restricted stock units vest upon the completion of the three-year period ending January 1, 2023. In the event that the services of the Reporting Person cease prior to the expiration of such three-year period, the restricted stock units will vest upon the cessation of service, provided however that the number of restricted stock units that vest will be reduced pro rata to the extent of the portion of the three-year period not served. Each restricted stock unit represents a right to receive one share of the Registrant's common stock. Read SEC document |
| January 02, 2019 Filed Jan 2, 2019 22:27 UTC | VISHAY INTERTECHNOLOGY INC VSH · Entity 3973 | GrantCommon Stock | 9,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-000109 · doc1.xml · nonDerivative · entry 1 LUDOMIRSKI ABRAHAM · CIK 0001235402 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,346 F1 · shares: Represents the number of restricted stock units granted to the Reporting Person on January 2, 2019 as part of the Registrant's 2007 Stock Incentive Program. The restricted stock units vest upon the completion of the three-year period ending January 1, 2022. In the event that the services of the Reporting Person cease prior to the expiration of such three-year period, the restricted stock units will vest upon the cessation of service, provided however that the number of restricted stock units that vest will be reduced pro rata to the extent of the portion of the three-year period not served. Each restricted stock unit represents a right to receive one share of the Registrant's common stock. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 22:10 UTC | VISHAY INTERTECHNOLOGY INC VSH · Entity 3973 | GrantCommon Stock | 7,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-000497 · doc1.xml · nonDerivative · entry 1 LUDOMIRSKI ABRAHAM · CIK 0001235402 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,184 F1 · shares: Represents the number of restricted stock units granted to the Reporting Person on January 2, 2018 as part of the Registrant's 2007 Stock Incentive Program. The restricted stock units vest upon the completion of the three-year period ending January 1, 2021. In the event that the services of the Reporting Person cease prior to the expiration of such three-year period, the restricted stock units will vest upon the cessation of service, provided however that the number of restricted stock units that vest will be reduced pro rata to the extent of the portion of the three-year period not served. Each restricted stock unit represents a right to receive one share of the Registrant's common stock. Read SEC document |
| October 30, 2017 Filed Oct 30, 2017 20:18 UTC | VISHAY INTERTECHNOLOGY INC VSH · Entity 3973 | SaleCommon Stock | 20,000 | $21.79 | $435,800.00 |
DisclosureSEC source: 0001140361-17-040042 · doc1.xml · nonDerivative · entry 1 LUDOMIRSKI ABRAHAM · CIK 0001235402 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,232 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.78 to $21.84, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of each separate price within the ranges set forth in this footnote to the Form 4. Read SEC document |
| June 27, 2017 Filed Jun 28, 2017 20:28 UTC | Lifeward Ltd. RWLK · Entity 7620 | SaleOrdinary Shares, par value NIS 0.01 per share | 12,511 | $3.09 | $38,697.77 |
DisclosureSEC source: 0001144204-17-034636 · v469916_4.xml · nonDerivative · entry 2 SCP Vitalife Partners (Israel) II, L.P. · CIK 0001602484 · 10% owner SCP Vitalife II Associates, L.P. · CIK 0001662464 · 10% owner SCP Vitalife II GP, Ltd. · CIK 0001662461 · 10% owner CHURCHILL WINSTON J · CIK 0000923792 · 10% owner LUDOMIRSKI ABRAHAM · CIK 0001235402 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,900 F1 · kind: Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 15, 2016. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.0000 to $3.2000, inclusive. The reporting person undertakes to provide to ReWalk Robotics, Ltd. ("ReWalk"), any security holder of ReWalk, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F2 · ownership.direct: The Ordinary Shares are directly held by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife") and indirectly held by SCP Vitalife II Associates, L.P. ("SCP Vitalife Associates"), the sole general partner of SCP Vitalife, SCP Vitalife II, GP, Ltd. ("SCP Vitalife GP"), the sole general partner of SCP Vitalife Associates, and the individual directors of SCP Vitalife GP (SCP Vitalife Associates, SCP Vitalife GP and the individual directors of SCP Vitalife GP together, the "SCP Vitalife Indirect Reporting Persons"). The individual directors of SCP Vitalife GP are Jeffrey Dykan, Winston J. Churchill, Abraham Ludomirski and Wayne B. Weisman. The SCP Vitalife Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the SCP Vitalife Ordinary Shares in which the SCP Vitalife Indirect Reporting Persons have no pecuniary interest. Read SEC document |
| June 27, 2017 Filed Jun 28, 2017 20:25 UTC | Lifeward Ltd. RWLK · Entity 7620 | SaleOrdinary Shares, par value NIS 0.01 per share | 37,459 | $3.09 | $115,864.43 |
DisclosureSEC source: 0001144204-17-034631 · v469912_4.xml · nonDerivative · entry 2 SCP Vitalife Partners II LP · CIK 0001398330 · 10% owner SCP Vitalife II Associates, L.P. · CIK 0001662464 · 10% owner SCP Vitalife II GP, Ltd. · CIK 0001662461 · 10% owner CHURCHILL WINSTON J · CIK 0000923792 · 10% owner LUDOMIRSKI ABRAHAM · CIK 0001235402 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,017,674 F1 · kind: Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 15, 2016. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.0000 to $3.2000, inclusive. The reporting person undertakes to provide to ReWalk Robotics, Ltd. ("ReWalk"), any security holder of ReWalk, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F2 · ownership.direct: The Ordinary Shares are directly held by SCP Vitalife Partners II, L.P. ("SCP Vitalife") and indirectly held by SCP Vitalife II Associates, L.P. ("SCP Vitalife Associates"), the sole general partner of SCP Vitalife, SCP Vitalife II, GP, Ltd. ("SCP Vitalife GP"), the sole general partner of SCP Vitalife Associates, and the individual directors of SCP Vitalife GP (SCP Vitalife Associates, SCP Vitalife GP and the individual directors of SCP Vitalife GP together, the "SCP Vitalife Indirect Reporting Persons"). The individual directors of SCP Vitalife GP are Jeffrey Dykan, Winston J. Churchill, Abraham Ludomirski and Wayne B. Weisman. The SCP Vitalife Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the SCP Vitalife Ordinary Shares in which the SCP Vitalife Indirect Reporting Persons have no pecuniary interest. Read SEC document |
| June 26, 2017 Filed Jun 28, 2017 20:28 UTC | Lifeward Ltd. RWLK · Entity 7620 | SaleOrdinary Shares, par value NIS 0.01 per share | 9,271 | $3.00 | $27,813.00 |
DisclosureSEC source: 0001144204-17-034636 · v469916_4.xml · nonDerivative · entry 1 SCP Vitalife Partners (Israel) II, L.P. · CIK 0001602484 · 10% owner SCP Vitalife II Associates, L.P. · CIK 0001662464 · 10% owner SCP Vitalife II GP, Ltd. · CIK 0001662461 · 10% owner CHURCHILL WINSTON J · CIK 0000923792 · 10% owner LUDOMIRSKI ABRAHAM · CIK 0001235402 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 352,411 F1 · kind: Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 15, 2016. F2 · ownership.direct: The Ordinary Shares are directly held by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife") and indirectly held by SCP Vitalife II Associates, L.P. ("SCP Vitalife Associates"), the sole general partner of SCP Vitalife, SCP Vitalife II, GP, Ltd. ("SCP Vitalife GP"), the sole general partner of SCP Vitalife Associates, and the individual directors of SCP Vitalife GP (SCP Vitalife Associates, SCP Vitalife GP and the individual directors of SCP Vitalife GP together, the "SCP Vitalife Indirect Reporting Persons"). The individual directors of SCP Vitalife GP are Jeffrey Dykan, Winston J. Churchill, Abraham Ludomirski and Wayne B. Weisman. The SCP Vitalife Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the SCP Vitalife Ordinary Shares in which the SCP Vitalife Indirect Reporting Persons have no pecuniary interest. Read SEC document |
| June 26, 2017 Filed Jun 28, 2017 20:25 UTC | Lifeward Ltd. RWLK · Entity 7620 | SaleOrdinary Shares, par value NIS 0.01 per share | 27,759 | $3.00 | $83,277.00 |
DisclosureSEC source: 0001144204-17-034631 · v469912_4.xml · nonDerivative · entry 1 SCP Vitalife Partners II LP · CIK 0001398330 · 10% owner SCP Vitalife II Associates, L.P. · CIK 0001662464 · 10% owner SCP Vitalife II GP, Ltd. · CIK 0001662461 · 10% owner CHURCHILL WINSTON J · CIK 0000923792 · 10% owner LUDOMIRSKI ABRAHAM · CIK 0001235402 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,055,133 F1 · kind: Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 15, 2016. F2 · ownership.direct: The Ordinary Shares are directly held by SCP Vitalife Partners II, L.P. ("SCP Vitalife") and indirectly held by SCP Vitalife II Associates, L.P. ("SCP Vitalife Associates"), the sole general partner of SCP Vitalife, SCP Vitalife II, GP, Ltd. ("SCP Vitalife GP"), the sole general partner of SCP Vitalife Associates, and the individual directors of SCP Vitalife GP (SCP Vitalife Associates, SCP Vitalife GP and the individual directors of SCP Vitalife GP together, the "SCP Vitalife Indirect Reporting Persons"). The individual directors of SCP Vitalife GP are Jeffrey Dykan, Winston J. Churchill, Abraham Ludomirski and Wayne B. Weisman. The SCP Vitalife Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the SCP Vitalife Ordinary Shares in which the SCP Vitalife Indirect Reporting Persons have no pecuniary interest. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 21:02 UTC | VISHAY INTERTECHNOLOGY INC VSH · Entity 3973 | GrantCommon Shares | 10,185 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-000358 · doc1.xml · nonDerivative · entry 1 LUDOMIRSKI ABRAHAM · CIK 0001235402 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,232 F1 · shares: Represents the number of restricted stock units granted to the Reporting Person on January 3, 2017 as part of the Registrant's 2007 Stock Incentive Program. The restricted stock units vest upon the completion of the three-year period ending January 1, 2020. In the event that the services of the Reporting Person cease prior to the expiration of such three-year period, the restricted stock units will vest upon the cessation of service, provided however that the number of restricted stock units that vest will be reduced pro rata to the extent of the portion of the three-year period not served. Each restricted stock unit represents a right to receive one share of the Registrant's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.